ALNY
Price
$446.97
Change
-$4.76 (-1.05%)
Updated
Sep 18, 12:10 PM (EDT)
Capitalization
60.46B
35 days until earnings call
BEAM
Price
$24.24
Change
+$1.79 (+7.97%)
Updated
Sep 18, 12:12 PM (EDT)
Capitalization
2.32B
53 days until earnings call
Interact to see
Advertisement

ALNY vs BEAM

Header iconALNY vs BEAM Comparison
Open Charts ALNY vs BEAMBanner chart's image
Alnylam Pharmaceuticals
Price$446.97
Change-$4.76 (-1.05%)
Volume$776
Capitalization60.46B
Beam Therapeutics
Price$24.24
Change+$1.79 (+7.97%)
Volume$1.3K
Capitalization2.32B
ALNY vs BEAM Comparison Chart in %
Loading...
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALNY vs. BEAM commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALNY is a Hold and BEAM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (ALNY: $451.73 vs. BEAM: $22.49)
Brand notoriety: ALNY and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALNY: 124% vs. BEAM: 129%
Market capitalization -- ALNY: $60.46B vs. BEAM: $2.32B
ALNY [@Biotechnology] is valued at $60.46B. BEAM’s [@Biotechnology] market capitalization is $2.32B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALNY’s FA Score shows that 1 FA rating(s) are green whileBEAM’s FA Score has 1 green FA rating(s).

  • ALNY’s FA Score: 1 green, 4 red.
  • BEAM’s FA Score: 1 green, 4 red.
According to our system of comparison, both ALNY and BEAM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALNY’s TA Score shows that 3 TA indicator(s) are bullish while BEAM’s TA Score has 5 bullish TA indicator(s).

  • ALNY’s TA Score: 3 bullish, 5 bearish.
  • BEAM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than ALNY.

Price Growth

ALNY (@Biotechnology) experienced а -3.75% price change this week, while BEAM (@Biotechnology) price change was +13.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.28%. For the same industry, the average monthly price growth was +6.08%, and the average quarterly price growth was +34.58%.

Reported Earning Dates

ALNY is expected to report earnings on Oct 23, 2025.

BEAM is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+1.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALNY($60.5B) has a higher market cap than BEAM($2.32B). ALNY YTD gains are higher at: 91.970 vs. BEAM (-9.335). ALNY has higher annual earnings (EBITDA): -170.84M vs. BEAM (-414.33M). ALNY has more cash in the bank: 2.86B vs. BEAM (1.15B). BEAM has less debt than ALNY: BEAM (155M) vs ALNY (1.3B). ALNY has higher revenues than BEAM: ALNY (2.46B) vs BEAM (60.3M).
ALNYBEAMALNY / BEAM
Capitalization60.5B2.32B2,610%
EBITDA-170.84M-414.33M41%
Gain YTD91.970-9.335-985%
P/E RatioN/AN/A-
Revenue2.46B60.3M4,083%
Total Cash2.86B1.15B249%
Total Debt1.3B155M837%
FUNDAMENTALS RATINGS
ALNY: Fundamental Ratings
ALNY
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
8
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALNYBEAM
RSI
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
72%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
64%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 10 days ago
76%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
64%
Bearish Trend 17 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QKBGX23.72N/A
N/A
Federated Hermes MDT Balanced R6
FINVX16.27N/A
N/A
Fidelity Series International Value
WCMJX11.52N/A
N/A
WCM SMID Quality Val Fd Investor
OPMYX35.73N/A
N/A
Invesco Main Street Mid Cap Y
ARYNX13.81N/A
N/A
American Century Global Real Estate I

ALNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALNY has been loosely correlated with IONS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ALNY jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALNY
1D Price
Change %
ALNY100%
-2.06%
IONS - ALNY
45%
Loosely correlated
-0.24%
SGMO - ALNY
42%
Loosely correlated
-0.29%
ARGX - ALNY
40%
Loosely correlated
-2.39%
INSM - ALNY
38%
Loosely correlated
+0.02%
AXSM - ALNY
38%
Loosely correlated
+2.21%
More

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-1.86%
CRSP - BEAM
66%
Closely correlated
-3.46%
NTLA - BEAM
63%
Loosely correlated
+1.14%
RXRX - BEAM
61%
Loosely correlated
-2.58%
AXON - BEAM
57%
Loosely correlated
+0.15%
SYRE - BEAM
56%
Loosely correlated
+1.82%
More